Non-canonical NF-B signaling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation Li et al. (Nature Cell Biology, 2015) Manraj Gill April.

Slides:



Advertisements
Similar presentations
Cancer—Principles and overview By Robert A. Weinberg
Advertisements

Alterations in the Cell Cycle and Gene Mutations that Cause Cancer
TELOMERES What are they? Why are they important? Telomere shortening and the end-replication problem Telomerase Telomere hypothesis of aging.
Telomeres and Telomerase the internal clock is ticking…
TOPICS IN (NANO) BIOTECHNOLOGY Lecture 3 16th October, 2006 PhD Course.
Describe the structure of a nucleosome, the basic unit of DNA packaging in eukaryotic cells.
Cancer, Aging and Telomeres How molecular genetic research contributes to a better understanding of cancer and aging in humans.
Hallmarks of Cancer Six fundamental changes 1.Self sufficiency in growth factors 2.Insensitivity to growth-inhibitory signals 3.Evasion of apoptosis 4.Limitless.
Transfection The students need to have some background knowledge about recombinant DNA technology for this lecture. Key words: Transient transfection,
Video #: Cancer and its Causes Go to this site: Scroll down & Find “ Session 8: Cell Biology & Cancer Click.
How Genes are Controlled Chapter 11. Human Cells…. All share the same genome What makes them different????
Chapter 5: Cell Growth and Division
Tumor genetics Minna Thullberg
Cellular Senescence: A Link between Tumor Suppression and Organismal Aging.
Lecture #3 The Cell Cycle & Cancer
Which of the following functions are accomplished by cell division? a) growth, communication, and development b) growth, repair, and reproduction c) development,
Cancer Uncontrolled cell growth. Cellular differentiation is the process by which a less specialized cell becomes a more specialized cell type. Occurs.
Cancer --an Overview  Cell Division  Hormones and Cancer  Malignant Transformation  Angiogenesis and Metastasis  Growth.
Cancer. Regulation of Cell Division Two sets of genes control cell division. –Proto-oncogenes. Code for proteins that promote the cell cycle and prevent.
CANCER Definition Abnormal growth of cells that invade tissues and spread to other sites. Cell Regulation Normal Mitosis Reproduction occurs only when.
What is the difference between mitosis and meiosis?
The aging phenotype: cellular aspects A&S Jim Lund.
Gene Regulation and Cancer. Gene Regulation At any given time, most of the thousands of genes in a cell are not needed. How do cells “turn on” (express)
Chapter 11 Phage strategies.
The Cell Cycle Gone Awry Cancer and Mitosis. Mutagens give rise to cancer cells. There are a wide variety of mutagens which cause changes to our DNA:
The Genetic Basis of Development
When a cell copies a DNA molecule, each strand serves as a template for ordering nucleotides into a new complementary strand. DNA Replication The nucleotides.
Eukaryotic Genomes 15 November, 2002 Text Chapter 19.
Aging and Reactive oxygen Species. Aging: What is it?  Aging, has been termed generally as a progressive decline in the ability of a physiological process.
Chapter 12: The Cell Cycle
CONTROL OF GENE EXPRESSION The development of an organism must involve the switching on and off of genes in an orderly manner. This is not fully understood.
Video Homework Assignment “Cell Biology & Cancer” Reference Pgs: Chapter 12: pgs Chapter 19: pgs
Telomerase, Immortalization and Cancer Eric Bankaitis Cancer Bio 169 March 9, 2006 Fig.[9]
Genes and Development Chapter 16. Development All the changes that occur during an organism’s lifetime Cell specialization: Cell determination: specific.
TELOMERES &TELOMERASE 18 th Lecture Gihan E-H Gawish, MSc, PhD Ass. Professor Molecular Genetics and Clinical Biochemistry Molecular Genetics and Clinical.
Cell Aging. Aging is generally characterized by the declining ability to respond to stress, increasing homeostatic imbalance and increased risk of aging-associated.
CS173 Lecture 9: Transcriptional regulation III
Ch 11- Controlling Gene Expression
Chapter 27 Phage Strategies
The Cell Cycle and Cancer. How do we define cancer? Cancer is: 1. a disease of the cell cycle. 2. a group of disorders that cause some of the body’s cells.
Ch.12 Warm up 1. Define: genome, gametes, chromatin, chromosome, centromere, kinetochore, checkpoint, Cdk, MPF 2. What is the longest part of the cell.
Warm up  1. How is DNA packaged into Chromosomes?  2. What are pseudogenes?  3. Contrast DNA methylation to histone acetylation (remember the movie.
1 The Cell Cycle “Mitosis” Packet #33 Chapter #13 Friday, November 18, 2016.
DNA Replication (I) 王之仰.
Molecular Genetics: Part 2B Regulation of metabolic pathways:
GENETIC BASIS OF CANCER
Genes and Development CVHS Chapter 16.
DNA Replication and Repair
Bellringer Grab a sheet of paper from the front table. Identify the following structures? 2.___?__ 1.____?____.
Lecture #3 The Cell Cycle & Cancer
Question of the Day What is the correct phase of the cell cycle/mitosis for the following: Most cells that no longer divide or rarely divide are in this.
Chapter 12~ The Cell Cycle
Lecture #4 The Cell Cycle & Cancer
Alterations in the Cell Cycle and Gene Mutations that Cause Cancer
DNA Replication Lecture #23 Ms. Day Honors Biology.
Enabling Replicative Immortality
What makes a mutant?.
Clinical Genetics Lecture 4.
DNA Replication and Repair
Regulation of Gene Expression
Chapter 9: The Cell Cycle
The Cell Cycle.
K. Lenhard Rudolph, Daniel Hartmann, Oliver G. Opitz  Gastroenterology 
Chromosome structures
Environmental Carcinogenesis
Overview of Working With Telomeres and Cell Viability
Chapter 6 Section 2 The Cell Cycle Objectives
How to prevent and cure cancer and live forever
9.3 The Cell Cycle and Cancer
Neoplasia lecture 7 Dr Heyam Awad FRCPath.
Presentation transcript:

Non-canonical NF-B signaling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation Li et al. (Nature Cell Biology, 2015) Manraj Gill April 6th, 2016 Undergraduate Biology Journal Club

Preventing the loss of genetic information SOMATIC CELLS REPRODUCTIVE CELLS CELLULAR CLOCK Maintain majority of genetic information Shuffling of genetic information facilitated when linear! Starting off from the point of view of a cell… in the case of “regular cells” in the body, i.e. somatic cells and not sperm/egg cells, the important idea is that genetic information must be passed on to the new cells after cell division in the process of giving rise to or maintaining tissues. And, so, this information must remain largely intact and complete. You don’t want new cells to gradually lose this information and thereby not be “identical” to neighboring and ancestral cells! However, in the case of organismal reproduction, some variance has proven to be necessary because it leads to minute differences which evolution can act on. This impact which genetic information is more frequently passed on and a genetically diverse offspring can be better suited for survival in constantly changing conditions. To facilitate this diversity, and shuffling genetic information between individuals, a linear and non-circular carrier of genetic information, eukaryotic chromosomes, evolved since it served to be more efficient in recombining. But this evolution of linear genetic information threatens the ability of cells to retain the majority of this information because cells cannot effectively copy information in the ends. To prevent this loss, the cell evolved to develop a clock which allows it to roughly measure the number of times it has divided so that it knows to stop dividing when vital information would be at risk! “genetically identical” genetically diverse offspring Stops dividing when information is at risk!

The Cellular Clock Telomeres human Stem Cells Time / Divisions TR human Stem Cells Time / Divisions Telomere Length TERT human Somatic Cells Tumor Cells The cellular clock is in the form of a stretch of repetitive DNA sequence, called telomeres, at the ends of linear eukaryotic chromosomes. The telomeric length allows the cell to know whether or not its genetic information will be at risk when it divides. Every cell division, a portion of the telomeres is lost due to the DNA replication machinery’s inability to fully replicate the sequence in the terminal regions of each chromosome. Telomeres serve as buffer sequences at the ends to prevent loss of genetic information on the chromosome. Telomere shortening to critically small lengths over time due to cell divisions serves as a checkpoint for replicative senescence or cellular death because any further replication would threaten genetic stability. In stem cells, however, the length of the ends is maintained at a constant level. This makes sense because these cells have the potential of differentiating into all cell types in an organism and need to constantly give rise to new cell types. But the length can no longer be maintained at a constant level once this “stem-ness” is lost. Additionally, it has been observed that cancerous cells develop as a result of re-lengthening of these ends after the terminal length had been reached. The questions that my project addresses relate to the process by which this length is regulated. More specifically, what allows for a sustained telomere length in hESCs and what happens mechanistically to prevent this maintenance once the stem cell has differentiated. However, the telomerase enzyme can restore some lost telomeric sequence and increase the length of the telomere. In normal somatic cells, telomerase activity is absent because the transcription of the protein component of telomerase, TERT, is down regulated. However, cells with an unlimited potential to replicate, such as stem cells sustaining TERT expression. Telomerase Enzyme

Genome Wide Associate Studies (GWAS) observed three frequent non-coding mutations in the TERT promoter that are all associated with specific types of tumors

These three individual mutations that increase transcription each lead to the generation of de novo (new) binding site on the promoter for an ETS (E26 Transformation-Specific) family transcription factor G228A corresponds to -124 G>A G250A corresponds to -146 G>A

TNFa (tumor necrosis factor- alpha): canonical pathway NFκb (Nuclear Factor kappa-lightchain-enhancer of activated B cells) is a regulator of immunity stress responses apoptosis differentiation TNFa (tumor necrosis factor- alpha): canonical pathway TWEAK (TNF-like weak inducer of apoptosis): non-canonical pathway In contrast, a subset of GBM cell lines exhibited TERT induction following TWEAKexposure (Fig. 1a). Sequencing the TERT promoter region of these cell lines unexpectedly led to a distinct segregation of these lines that induce TERT after TWEAKstimulation, based on their TERT promoter mutation status (Fig. 1b). Upregulation of TERT in GBM cells containing the C250T mutation correlated with a strong induction of telomerase activity in C250T-mutant cells (Fig. 1c). It is noteworthy that small changes in TERT transcription are sucient for a significant increase in telomerase activity These results suggest that although similar levels of p52/RelB are activated in all GBM cells, only the C250T-mutant TERT promoter is responsive to these dimers. Oeckinghaus et al. Nature Immunology (2011)

Lentiviral knockdown of p52, RelB and NIK abolished the induction of TERT in TWEAK-stimulated C250T GBM cells Lentiviral knockdown of p52, RelB and NIK abolished the induction of TERT in TWEAK-stimulated C250T GBM cells

p52 binds to half-sites in vivo We thus examined whether p52 can bind half-site at the C250T TERT promoter using the only available in vivo p52 ChIP-seq data fromlymphoblastoid B cells37. Through de novomotif analysis3840,we identified the palindromic p52 motif from 12,239 p52 ChIP-seq peaks In contrast, 11 base pairswith lower full-site binding anity regions tend to enrich in the half-site binding regions (Fig. 2barea in rectangles)where only one of the half-site GL or GR is low41. We therefore provide evidence that p52 binds to half-sites in vivo.

These findings highlight the significant concordance be- tween enhanced NIK expression and increased telomerase expression in GBM tumours carrying the C250T mutation.